Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
1,054.89
1,200.09
1,016.94
853.17
712.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,054.89
1,200.09
1,016.94
853.17
712.93
Raw Material Cost
254.35
264.31
184.54
167.07
157.26
Purchase of Finished goods
62.61
55.99
56.74
28.77
30.73
(Increase) / Decrease In Stocks
-71.28
-14.79
-12.08
-15.63
-23.98
Employee Cost
176.90
138.93
123.05
110.28
95.69
Power Cost
116.20
112.23
104.97
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
148.72
137.09
128.16
219.39
179.96
Total Expenditure (Excl Depreciation)
687.49
693.76
585.38
509.88
439.66
Operating Profit (PBDIT) excl Other Income
367.40
506.33
431.56
343.29
273.27
Other Income
52.36
44.45
33.78
35.31
23.42
Operating Profit (PBDIT)
419.76
550.78
465.34
378.60
296.69
Interest
0.28
0.53
2.55
4.51
5.48
Exceptional Items
-3.28
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
416.20
550.25
462.79
374.09
291.21
Depreciation
74.46
54.37
53.59
54.03
50.05
Profit Before Tax
341.74
495.87
409.20
320.05
241.16
Tax
85.42
122.91
104.46
81.93
62.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
256.32
372.96
304.73
238.13
178.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
256.32
372.96
304.73
238.13
178.57
Share in Profit of Associates
2.91
-1.32
3.37
1.96
-3.64
Minority Interest
1.68
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
260.91
371.64
308.10
240.09
174.93
Equity Capital
10.46
10.46
10.46
10.46
9.51
Face Value
1.0
1.0
1.0
1.0
10.0
Reserves
2,006.60
1,802.26
1,516.18
1,279.54
1,093.71
Earnings per share (EPS)
24.94
35.53
29.46
22.95
16.72
Diluted Earnings per share
24.78
35.52
29.45
22.95
183.34
Operating Profit Margin (Excl OI)
34.83%
42.19%
42.44%
40.24%
38.33%
Gross Profit Margin
39.45%
45.85%
45.51%
43.85%
40.85%
PAT Margin
24.57%
30.97%
30.3%
28.14%
24.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -12.10% vs 18.01% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -29.79% vs 20.62% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -27.44% vs 17.33% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -47.17% vs -79.22% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Concord Biotech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,054.89
7,344.90
-6,290.01
-85.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,054.89
7,344.90
-6,290.01
-85.64%
Raw Material Cost
254.35
1,747.38
-1,493.03
-85.44%
Purchase of Finished goods
62.61
508.88
-446.27
-87.70%
(Increase) / Decrease In Stocks
-71.28
-271.81
200.53
73.78%
Employee Cost
176.90
1,731.93
-1,555.03
-89.79%
Power Cost
116.20
0.00
116.20
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
148.72
2,510.06
-2,361.34
-94.08%
Total Expenditure (Excl Depreciation)
687.49
6,226.44
-5,538.95
-88.96%
Operating Profit (PBDIT) excl Other Income
367.40
1,118.46
-751.06
-67.15%
Other Income
52.36
54.41
-2.05
-3.77%
Operating Profit (PBDIT)
419.76
1,172.87
-753.11
-64.21%
Interest
0.28
93.63
-93.35
-99.70%
Exceptional Items
-3.28
-66.99
63.71
95.10%
Gross Profit (PBDT)
416.20
1,012.25
-596.05
-58.88%
Depreciation
74.46
318.55
-244.09
-76.63%
Profit Before Tax
341.74
693.70
-351.96
-50.74%
Tax
85.42
23.12
62.30
269.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
256.32
670.58
-414.26
-61.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
256.32
670.58
-414.26
-61.78%
Share in Profit of Associates
2.91
0.25
2.66
1,064.00%
Minority Interest
1.68
3.94
-2.26
-57.36%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
260.91
674.77
-413.86
-61.33%
Equity Capital
10.46
39.31
-28.85
-73.39%
Face Value
1.00
2.00
0.00
Reserves
2,006.60
5,635.50
-3,628.90
-64.39%
Earnings per share (EPS)
24.94
34.33
-9.39
-27.35%
Diluted Earnings per share
24.78
34.33
-9.55
-27.82%
Operating Profit Margin (Excl OI)
34.83%
15.23%
0.00
19.60%
Gross Profit Margin
39.45%
13.78%
0.00
25.67%
PAT Margin
24.57%
9.13%
0.00
15.44%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,054.89 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -12.10% vs 18.01% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 260.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -29.79% vs 20.62% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 367.40 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -27.44% vs 17.33% in Mar 2025
Annual - Interest
Interest 0.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -47.17% vs -79.22% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.83%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
